Jiang D - Search Results

1

Impact of Nasogastric Decompression on Gastric Tube Size After McKeown Minimally Invasive Esophagectomy: a Retrospective Controlled Cohort Study.

Jiang D, Liu XB, Xing WQ, Chen PN, Feng SK, Liu JX, Sun HB. Jiang D, et al. J Gastrointest Surg. 2022 Dec;26(12):2585-2587. doi: 10.1007/s11605-022-05406-w. Epub 2022 Jul 11. J Gastrointest Surg. 2022. PMID: 35819665 No abstract available.

2

Adjuvant Chemotherapy for Node-positive Esophageal Squamous Cell Carcinoma Improves Survival.

Feng SK, Liu XB, Xing WQ, Liu Y, Chen PN, Jiang D, Sun HB. Feng SK, et al. Among authors: jiang d. Ann Thorac Surg. 2022 Oct;114(4):1205-1213. doi: 10.1016/j.athoracsur.2021.08.068. Epub 2021 Oct 6. Ann Thorac Surg. 2022. PMID: 34626616

3

Perioperative Outcomes and Learning Curve of Robot-Assisted McKeown Esophagectomy.

Sun HB, Jiang D, Liu XB, Xing WQ, Liu SL, Chen PN, Li P, Ma YX. Sun HB, et al. Among authors: jiang d. J Gastrointest Surg. 2023 Jan;27(1):17-26. doi: 10.1007/s11605-022-05484-w. Epub 2022 Oct 19. J Gastrointest Surg. 2023. PMID: 36261780

4

Survival impact of the number of lymph nodes dissection in patients receiving neoadjuvant chemotherapy for esophageal squamous cell carcinoma.

Jiang D, Liu XB, Xing WQ, Chen PN, Feng SK, Yan S, Lerut T, Sun HB. Jiang D, et al. Dis Esophagus. 2023 Apr 29;36(5):doac082. doi: 10.1093/dote/doac082. Dis Esophagus. 2023. PMID: 36385581

5

Initial experience with modified en bloc robot-assisted minimally invasive oesophagectomy for thoracic oesophageal squamous cell carcinoma.

Sun HB, Liu XB, Xing WQ, Chen PN, Liu SL, Li P, Ma YX, Feng SK, Jiang D, Yan S. Sun HB, et al. Among authors: jiang d. Int J Med Robot. 2023 Jun;19(3):e2506. doi: 10.1002/rcs.2506. Epub 2023 Feb 17. Int J Med Robot. 2023. PMID: 36786383

6

Patterns and Influence of Lymph Nodal Metastases After Neoadjuvant Chemotherapy and Surgery for Thoracic Esophageal Squamous Cell Carcinoma.

Sun HB, Jiang D, Liu XB, Xing WQ, Chen PN, Feng SK, Yan S. Sun HB, et al. Among authors: jiang d. Ann Surg Oncol. 2023 Aug;30(8):5205-5212. doi: 10.1245/s10434-023-13634-w. Epub 2023 May 10. Ann Surg Oncol. 2023. PMID: 37162643

7

[No title available]

[No authors listed] [No authors listed] PMID: 37285098

8

ASO Author Reflections: Lymphadenectomy for Esophageal Cancer in the Era of Neoadjuvant Therapy.

Yan S, Jiang D, Liu XB, Xing WQ, Chen PN, Feng SK, Sun HB. Yan S, et al. Among authors: jiang d. Ann Surg Oncol. 2023 Nov;30(12):7501-7502. doi: 10.1245/s10434-023-13924-3. Epub 2023 Jul 14. Ann Surg Oncol. 2023. PMID: 37450094 No abstract available.

9

The prognostic impact of tumor length on pathological stage IA-IC esophageal adenocarcinoma.

Yan S, Liu X, Xing W, Jiang D, Feng SK, Chang AC, Sun HB. Yan S, et al. Among authors: jiang d. Dis Esophagus. 2024 Jan 1;37(1):doad046. doi: 10.1093/dote/doad046. Dis Esophagus. 2024. PMID: 37455547

10

A multicenter randomized, controlled clinical trial of adjuvant sintilimab for esophageal squamous cell carcinoma.

Sun HB, Xing WQ, Liu XB, Yang SJ, Chen PN, Liu SL, Li P, Ma YX, Jiang D, Yan S. Sun HB, et al. Among authors: jiang d. Future Oncol. 2023 Aug;19(26):1777-1784. doi: 10.2217/fon-2022-1255. Epub 2023 Sep 22. Future Oncol. 2023. PMID: 37737025 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,361 results

Search Page

Filters